Signaturefd, LLC Cara Therapeutics, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$4.89 - $12.27 $772 - $1,938	158 Added 45.66%	504 $2,000
Q4 2022 Jan 27, 2023	SELL	$8.88 - $12.77 $1,918 - $2,758	-216 Reduced 38.43%	346 $3,000
Q3 2022 Nov 08, 2022	BUY	$8.24 - $12.56 $4,169 - $6,355	506 Added 903.57%	562 $5,000
Q2 2022 Aug 10, 2022	SELL	$7.45 - $13.84 $521 - $968	-70 Reduced 55.56%	56 $1,000
Q1 2022 May 02, 2022	BUY	$9.94 - $12.65 $1,252 - $1,593	126 New	126 $2,000
Q2 2021 Jul 26, 2021	SELL	$12.38 - $29.19 $408 - $963	-33 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$15.07 - $21.71 $497 - $716	33 New	33 $1,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.